ID

34291

Descrição

A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01999322

Link

https://clinicaltrials.gov/show/NCT01999322

Palavras-chave

  1. 16/01/2019 16/01/2019 -
Titular dos direitos

see on clinicaltrials.gov

Transferido a

16 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diabetes NCT01999322

Eligibility Diabetes NCT01999322

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01999322
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, age at least 18 years at the time of signing inform consent
Descrição

ID.1

Tipo de dados

boolean

type 1 diabetes mellitus (diagnosed clinically) for at least 12 months at the time of screening (visit 1)
Descrição

ID.2

Tipo de dados

boolean

currently treated with insulin aspart, insulin lispro or insulin gluisine for at least 3 months prior to screening (visit 1)
Descrição

ID.3

Tipo de dados

boolean

using an external csii system for the previous 6 months prior to screening (visit 1)
Descrição

ID.4

Tipo de dados

boolean

hba1c (glycosylated haemoglobin) below or equal to 9.0% as assessed by central laboratory
Descrição

ID.5

Tipo de dados

boolean

body mass index (bmi) 20.0-35.0 kg/m^2
Descrição

ID.6

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of diabetic ketoacidosis (dka) episodes requiring hospitalization within 6 months prior to screening (visit 1)
Descrição

ID.7

Tipo de dados

boolean

history of abscess at the infusion site within 6 months prior to screening (visit 1)
Descrição

ID.8

Tipo de dados

boolean

hypoglycaemic unawareness as judged by the investigator or history of severe hypoglycaemic episodes requiring hospitalization within the last 6 months prior to screening (visit 1)
Descrição

ID.9

Tipo de dados

boolean

Similar models

Eligibility Diabetes NCT01999322

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01999322
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male or female, age at least 18 years at the time of signing inform consent
boolean
ID.2
Item
type 1 diabetes mellitus (diagnosed clinically) for at least 12 months at the time of screening (visit 1)
boolean
ID.3
Item
currently treated with insulin aspart, insulin lispro or insulin gluisine for at least 3 months prior to screening (visit 1)
boolean
ID.4
Item
using an external csii system for the previous 6 months prior to screening (visit 1)
boolean
ID.5
Item
hba1c (glycosylated haemoglobin) below or equal to 9.0% as assessed by central laboratory
boolean
ID.6
Item
body mass index (bmi) 20.0-35.0 kg/m^2
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
history of diabetic ketoacidosis (dka) episodes requiring hospitalization within 6 months prior to screening (visit 1)
boolean
ID.8
Item
history of abscess at the infusion site within 6 months prior to screening (visit 1)
boolean
ID.9
Item
hypoglycaemic unawareness as judged by the investigator or history of severe hypoglycaemic episodes requiring hospitalization within the last 6 months prior to screening (visit 1)
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial